RACHEL GRAVINA: Open Payments
NPI 1700591906 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,169 in 53 payments from 14 companies in 2025. Trend: 2023 $202 · 2024 $815 · 2025 $1,169
Food & beverage: $1,169
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $321 |
| Aimmune Therapeutics, Inc. | 13 | $289 |
| VIVUS LLC | 6 | $136 |
| Ardelyx, Inc. | 5 | $119 |
| QOL Medical, LLC | 2 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| PFIZER INC. | 1 | $40 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $24 |
Products named: ZENPEP, PANCREAZE, IBSRELA, LINZESS, VIBERZI, RINVOQ, CREON, Sucraid.
Industry payments across NY — which companies pay providers there.
